Please assess the completion status of the following clinical trial:

Trial Title: Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-70 yrs, male and females, with T2DM, on metformin alone or in combination with 1 other oral agent~Exclusion Criteria:~* Subjects with recent cardiovascular events, those with evidence of diabetic complications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo to match PF-04937319 and glimepiride
- PF-04937319 10 mg (Type: EXPERIMENTAL): None
- PF-04937319 50 mg (Type: EXPERIMENTAL): None
- PF-04937319 100 mg (Type: EXPERIMENTAL): None
- Glimepiride (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).